Eric Haseltine
Eric Haseltine
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Approximate simulation of coupled fast and slow reactions for stochastic chemical kinetics
EL Haseltine, JB Rawlings
The Journal of chemical physics 117 (15), 6959-6969, 2002
Critical evaluation of extended Kalman filtering and moving-horizon estimation
EL Haseltine, JB Rawlings
Industrial & engineering chemistry research 44 (8), 2451-2460, 2005
Synthetic gene circuits: design with directed evolution
EL Haseltine, FH Arnold
Annu. Rev. Biophys. Biomol. Struct. 36, 1-19, 2007
Two classes of quasi-steady-state model reductions for stochastic kinetics
EA Mastny, EL Haseltine, JB Rawlings
The Journal of chemical physics 127 (9), 2007
Implications of rewiring bacterial quorum sensing
EL Haseltine, FH Arnold
Applied and environmental microbiology 74 (2), 437-445, 2008
On the origins of approximations for stochastic chemical kinetics
EL Haseltine, JB Rawlings
The Journal of chemical physics 123 (16), 2005
Ivacaftor in infants aged 4 to< 12 months with cystic fibrosis and a gating mutation. Results of a two-part phase 3 clinical trial
JC Davies, CE Wainwright, GS Sawicki, MN Higgins, D Campbell, ...
American journal of respiratory and critical care medicine 203 (5), 585-593, 2021
Initialization strategies for optimization of dynamic systems
SM Safdarnejad, JD Hedengren, NR Lewis, EL Haseltine
Computers & Chemical Engineering 78, 39-50, 2015
A phase 3 study of tezacaftor in combination with ivacaftor in children aged 6 through 11 years with cystic fibrosis
S Walker, P Flume, J McNamara, M Solomon, M Chilvers, J Chmiel, ...
Journal of Cystic Fibrosis 18 (5), 708-713, 2019
Dynamics of viral infections: incorporating both the intracellular and extracellular levels
EL Haseltine, JB Rawlings, J Yin
Computers & chemical engineering 29 (3), 675-686, 2005
A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with …
JC Davies, I Sermet-Gaudelus, L Naehrlich, RS Harris, D Campbell, ...
Journal of Cystic Fibrosis 20 (1), 68-77, 2021
Image-guided modeling of virus growth and spread
EL Haseltine, V Lam, J Yin, JB Rawlings
Bulletin of mathematical biology 70, 1730-1748, 2008
On the stochastic simulation of particulate systems
EL Haseltine, DB Patience, JB Rawlings
Chemical Engineering Science 60 (10), 2627-2641, 2005
Physiologically based pharmacokinetic modeling of CFTR modulation in people with cystic fibrosis transitioning from mono or dual regimens to triple-combination elexacaftor …
A Tsai, SP Wu, E Haseltine, S Kumar, SM Moskowitz, P Panorchan, ...
Pulmonary therapy 6, 275-286, 2020
Stochastic simulation of catalytic surface reactions in the fast diffusion limit
EA Mastny, EL Haseltine, JB Rawlings
The Journal of chemical physics 125 (19), 2006
The stochastic quasi-steady-state assumption: reducing the model but not the noise
R Srivastava, EL Haseltine, E Mastny, JB Rawlings
The Journal of chemical physics 134 (15), 2011
Implications of decoupling the intracellular and extracellular levels in multi‐level models of virus growth
EL Haseltine, J Yin, JB Rawlings
Biotechnology and bioengineering 101 (4), 811-820, 2008
Successful treatment with telaprevir‐based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis
EL Haseltine, MS Penney, S George, TL Kieffer
Journal of Viral Hepatitis 22 (9), 701-707, 2015
Systems analysis of stochastic and population balance models for chemically reacting systems
EL Haseltine
The University of Wisconsin-Madison, 2005
Pharmaceutical compositions for treating cystic fibrosis
C Chu, V Dhamankar, E Dokou, EL Haseltine, S Moskowitz, S Robertson, ...
US Patent 11,179,367, 2021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20